Encision's Q4 revenue falls 12%, impacted by fewer selling days

Encision

13/04/2026 16:30

Overview

US medical device maker's fiscal Q4 revenue fell 12% from prior quarter

Company completed restructuring, cutting operating expenses by 23% quarter-over-quarter

Encision expects next quarter to be profitable after operating loss narrowed in Q4

Outlook

Encision expects next qtr sales to return to more typical levels

Company expects next qtr to be profitable after restructuring

Encision says cash flow forecast shows no going-concern considerations for next 12 months

Result Drivers

FEWER SELLING DAYS - Co said Q4 sales were partly impacted by fewer selling days in January and February

PROCEDURE SHIFT - Co said sales have continued to decline in part because procedures performed by Intuitive’s surgical robots have replaced procedures that have historically used our instrumentation

RESTRUCTURING - Co completed restructuring and reduced targeted operating expenses by end of February

Company press release: ID:nACSwyttla

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Product Revenue
$1.24 mln
Q4 Gross Profit
$592,000
Q4 Operating Expenses
$652,000
Q4 Operating Income
-$60,000


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)